John Hernandez

Insider

First SEC filing: Nov. 22, 2021 · Latest: Nov. 22, 2021

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 7 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

7 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
Nov. 20, 2025	RMD	A	1,073	—	—	5,118 Direct	+26.53%	Acquired	(price as of 2026-08-20)
Aug. 18, 2025	RMD	M	2,575	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-20)
Aug. 18, 2025	RMD	S	2,575	$287.10	$739,282	4,045 Direct	-38.90%	Disposed	-19.8% (price as of 2026-08-20)
Aug. 18, 2025	RMD	M	2,575	$148.90	$383,418	6,620 Direct	+63.66%	Acquired	54.7% (price as of 2026-08-20)
Nov. 20, 2024	RMD	A	1,083	—	—	4,045 Direct	+36.56%	Acquired	(price as of 2026-08-20)
Nov. 16, 2023	RMD	A	2,575	$148.90	$383,418	2,575 Direct	—	Acquired	54.7% (price as of 2026-08-20)
Nov. 16, 2023	RMD	A	884	—	—	2,962 Direct	+42.54%	Acquired	(price as of 2026-08-20)
Nov. 16, 2022	RMD	A	1,122	—	—	2,078 Direct	+117.36%	Acquired	(price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Aug. 18, 2025	RMD	ResMed Common Stock Options	ResMed Common Stock (2,575)	$148.90	Nov. 16, 2030	2,575	Disposed
Nov. 16, 2023	RMD	ResMed Common Stock Options	ResMed Common Stock (2,575)	$148.90	Nov. 16, 2030	2,575	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
Nov. 22, 2021	RMD	ResMed Common Stock	956	Direct